CLEPSO Meeting 2018 - Program

Clinical Epigenetics International Meeting

Thursday March 8th – Friday March 9th, 2018

Düsseldorf, Germany


Day one, March 8th, 2018

Get together 9:30 h – 10:00 h



Ulrich Mahlknecht, Conference Organizer


Keynote Speakers


Session Chairs: Lucia ALTUCCI and Janos MINAROVITS


10:00 h – 10:30 h Alessio SQUASSINA, University of Cagliari, Cagliari, Italy

Recent Trends on the Role of Epigenomics and Noncoding RNAs in Mood Stabilizing Treatment


10:30 h – 11:00 h Sam KEATING, Radboud Center for Infectious Diseases, Nijmegen, The Netherlands

Epigenetics and the Immune System


11:00 h – 11:30 h Jim DAVIE, University of Manitoba, Winnipeg, Canada

Epigenetic Profiling of Fetal Alcohol Syndrome and Type II Diabetes


11:30 h – 12:00 h Janos MINAROVITS, University of Szeged, Szeged, Hungary

Epigenetic Dysregulation Through Infectious Disease


Lunch break 12:00 h – 13:00 h


Session Chairs: Christian HEDRICH and Fabio COPPEDÈ


13:00 h – 13:30 h Lucia ALTUCCI, University of Naples, Naples, Italy

From Single-Target to Multi-Target Epigenetic Therapeutics


13:30 h – 14:00 h Christian HEDRICH, University of Liverpool, Liverpool, UK

On the Epigenetics of Systemic Lupus Erythematosus 


14:00 - 14:30 h Fabio COPPEDÈ, University of Pisa, Pisa, Italy

Pharmacoepigenetics and Pharmacoepigenomics of Gastrointestinal Cancers  


14:30 h – 15:00 h Pamela MUNSTER, University of California, San Francisco CA, USA

Select HDAC Enzyme Expression as Host Specific Biomarkers


Coffee break 15:00 h – 15:30 h


Session Chairs: Wolfgang WAGNER and Gerd PFEIFER


15:30 h – 16:00 h Gerd PFEIFER, Cancer for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA

Oxidation of 5-Methylcytosine in Development and Disease


16:00 h – 16:30 h Jesper Boje ANDERSEN, Univesity of Copenhagen, Copenhagen, Denmark 

Epigenetics of Cholangiocarcinoma


16:30 h – 17:00 h Charlotte LING, University of Lund, Malmö, Sweden

The Effects of High Glucose Exposure on Global Gene Expression and DNA Methylation in Human Pancreatic Islets.



End of Day one






Day two, March 9th, 2018


Session Chairs: Charlotte LING and Henk STUNNENBERG


9:00 h – 9:30 h Wim Van Den BERGHE, University of Antwerp, Belgium

BRCA Methylation Changes in Cancer and Cardiovascular Disease


9:30 h – 10:00 h David S. SCHRUMP, NIH, Bethesda, MD, USA

Epigenetics of Malignant Pleural Mesothelioma


10:00 h – 10:30 h Henk STUNNENBERG, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands 

The Interplay of Epigenetic Marks During Stem Cell Differentiation and Development.


Coffee break 10:30 h – 11:00 h


Session Chairs: Anton SHOSTAK and Wim Van Den BERGHE


11:00 h – 11:30 h Bart P.F. RUTTEN, Maastricht University Medical Centre, Maastricht, the Netherlands

On the Epigenetics of Aging, Neurodegeneration and Brain Cancer


11:30 h – 12:00 h Anton SHOSTAK, University of Heidelberg, Heidelberg, Germany

Circadian Clock, Cell Division, and Cancer: From Molecules to Organism.


12:00 h – 12:30 h Edyta RESZKA, Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Diseases, Lodz, Poland

Circadian Gene Variants and Breast Cancer.


Lunch break 12:00 h – 13:00 h


Session Chairs: Jim DAVIE and Michael SCHNEKENBURGER


13:30 h – 14:00 h Vessela N. KRISTENSEN, University of Oslo, Oslo, Norway

DNA Methylation at Enhancers Identifies Distinct Breast Cancer Lineages.


14:00 h – 14:30 h Arpad PATAI, Semmelweis University, Budapest, Hungary

Clinical Implications of DNA Methylation in Inflammatory Bowel Disease, Colorectal Polyps and Cancer


14:30 h – 15:00 h James D. FLANAGAN, Imperial College of London, London, UK

Epigenome-Wide Association Studies for Breast Cancer Risk and Risk Factors.


15:00 h Ulrich MAHLKNECHT

End of Congress, farewell


Farewell coffee break